Accelerating Innovation in the Medical Industry
Monday, April 30, 2012 / 8:00 am - 9:15 am


Michael Milken, Chairman, Milken Institute

Francis Collins, Director, National Institutes of Health
Margaret Hamburg, Commissioner, U.S. Food and Drug Administration
Freda Lewis-Hall, Executive Vice President, Chief Medical Officer, Pfizer, Inc.
Elias Zerhouni, President, Global Research & Development, Sanofi

Never has the promise of medical science appeared greater. A new era of personalized medicine seems to be at hand, promising longevity and improved quality of life. But realizing it is proving to be tougher and taking longer than expected. Progress has bogged down in the face of financing, regulatory and structural hurdles. With lives hanging in the balance, how can we create a more vibrant innovation ecosystem to shake up the status quo in medical science? What innovative models already exist in different disease research areas? How do we overcome a culture of risk aversion? How does the business model need to change? How can we direct more resources into prevention and early diagnosis rather than treating disease after the fact? This panel will discuss what it takes to push ideas forward and make change happen.